Pulmonary Complications in Fatal Yellow Fever, Brazil, 2017–2019

Read full text
Authors: Amaro N. Duarte-Neto, Katia C. Dantas, Suzette C. Ferreira, Fernando Giugni, Marielton P. Cunha, Shahab Zaki Pour, Felipe L Ledesma, Yeh-Li Ho, Ana C.S. Nastri, Cinthya S.C. Borges, Fernanda A. Rodrigues, Ceila M.S. Malaque
+5 more Jaques Sztajnbok, Thaís Mauad, Luiz F.F. Silva, Paulo HN Saldiva, Marisa Dolhnikoff
Cited by: 2
References: 29

Abstract

Yellow fever (YF) mainly causes severe hepatitis; data on pulmonary pathology remain limited. We investigated respiratory tract pathology in 73 fatal YF cases during the 2017-2019 epidemic in São Paulo, Brazil. All patients died from YF-related fulminant hepatitis. Autopsies revealed frequent tracheitis (91%), pulmonary edema and hemorrhage (100%), diffuse alveolar damage (84%), secondary pneumonia (84%), and bronchoaspiration (60%). Microabscesses, thrombi, and hemophagocytosis were also observed. In 5 cases of vaccine-associated viscerotropic disease, hemorrhage and diffuse alveolar damage were prominent. We detected antigens of YF virus in all cases and viral RNA in 94%. Molecular analysis identified bacterial and fungal pathogens in pneumonia, including gram-negative bacilli, Candida spp., and Aspergillus spp. Electron microscopy did not reveal viral particles in 3 examined cases. Our findings underscore the respiratory tract involvement in severe YF and could help guide diagnosis, intensive care, and public health preparedness in future outbreaks.

Fields of Study & Subjects

Mosquito-borne diseases and control Viral Infections and Outbreaks Research Viral Infections and Vectors

Publication details

Journal / source
Emerging infectious diseases
Publisher
Centers for Disease Control and Prevention (CDC)
Volume
32
Issue
2
Pages
211–224
Publication date
1 February 2026
Language
EN